Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · IEX Real-Time Price · USD
1.980
+0.060 (3.13%)
Apr 26, 2024, 3:49 PM EDT - Market closed
Can-Fite BioPharma Income Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.74 | 0.81 | 0.85 | 0.76 | 2.03 | 3.82 | 0.79 | 0.17 | 0.16 | 0 | Upgrade
|
| Revenue Growth (YoY) | -8.27% | -5.04% | 11.80% | -62.45% | -46.81% | 384.16% | 378.18% | 1.85% | - | - | Upgrade
|
| Gross Profit | 0.74 | 0.81 | 0.85 | 0.76 | 2.03 | 3.82 | 0.79 | 0.17 | 0.16 | 0 | Upgrade
|
| Selling, General & Admin | 2.96 | 3.14 | 3.85 | 2.95 | 3.06 | 3.16 | 2.87 | 2.73 | 2.74 | 3.12 | Upgrade
|
| Research & Development | 5.98 | 7.76 | 9.85 | 11.95 | 10.98 | 6.08 | 5.11 | 6.12 | 3.9 | 4.37 | Upgrade
|
| Operating Expenses | 8.94 | 10.91 | 13.7 | 14.9 | 14.04 | 9.23 | 7.97 | 8.85 | 6.64 | 7.5 | Upgrade
|
| Operating Income | -8.2 | -10.1 | -12.84 | -14.14 | -12.01 | -5.41 | -7.19 | -8.68 | -6.48 | -7.5 | Upgrade
|
| Interest Expense / Income | 0 | 0 | 0 | 0 | 0 | 1.15 | 0 | 0.06 | 0.13 | 0.33 | Upgrade
|
| Other Expense / Income | -0.56 | 0.08 | -0.23 | 0.3 | 0.62 | - | -3.1 | -16.91 | -13.02 | -14.48 | Upgrade
|
| Pretax Income | -7.63 | -10.17 | -12.62 | -14.44 | -12.63 | -6.57 | -4.08 | 8.17 | 6.41 | 6.65 | Upgrade
|
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0.03 | 0.01 | 0.01 | Upgrade
|
| Net Income | -7.63 | -10.17 | -12.62 | -14.44 | -12.63 | -6.57 | -4.11 | 8.14 | 6.4 | 6.65 | Upgrade
|
| Preferred Dividends | 0 | 0 | 2.59 | 0.72 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Net Income Growth | - | - | - | - | - | - | - | 27.16% | -3.73% | -15.87% | Upgrade
|
| Shares Outstanding (Basic) | 1,278 | 816 | 553 | 358 | 86 | 39 | 33 | 28 | 21 | 16 | Upgrade
|
| Shares Outstanding (Diluted) | 1,278 | 816 | 553 | 358 | 86 | 39 | 33 | - | - | - | Upgrade
|
| Shares Change | 56.71% | 47.49% | 54.31% | 317.19% | 120.84% | 19.61% | 17.53% | 29.82% | 35.75% | - | Upgrade
|
| EPS (Basic) | -3.00 | -3.00 | -9.00 | -12.00 | -42.00 | -51.00 | -42.00 | -90.00 | -81.00 | -109.35 | Upgrade
|
| EPS (Diluted) | -3.00 | -3.00 | -9.00 | -12.00 | -42.00 | -51.00 | -42.00 | -90.00 | -81.00 | -109.35 | Upgrade
|
| Free Cash Flow | -8.44 | -10.81 | -9.87 | -12.09 | -11.09 | -4.19 | -8.98 | -8.72 | -4.86 | -7.71 | Upgrade
|
| Free Cash Flow Per Share | -1.98 | -3.98 | -5.35 | -10.12 | -38.72 | -32.30 | -82.82 | -94.58 | -68.36 | -147.37 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | - | Upgrade
|
| Operating Margin | -1102.96% | -1246.42% | -1505.51% | -1853.08% | -590.90% | -141.73% | -910.65% | -5262.42% | -3998.15% | - | Upgrade
|
| Profit Margin | -1027.46% | -1255.93% | -1478.90% | -1892.92% | -621.31% | -172.02% | -521.17% | 4932.12% | 3950.62% | - | Upgrade
|
| Free Cash Flow Margin | -1136.20% | -1334.57% | -1156.98% | -1584.40% | -545.62% | -109.63% | -1138.02% | -5287.27% | -2998.15% | - | Upgrade
|
| Effective Tax Rate | - | - | - | - | - | - | - | 0.36% | 0.08% | 0.09% | Upgrade
|
| EBITDA | -7.53 | -10.11 | -12.55 | -14.42 | -12.61 | -5.4 | -4.06 | 8.24 | 6.55 | 7 | Upgrade
|
| EBITDA Margin | -1012.79% | -1247.53% | -1470.81% | -1890.17% | -620.62% | -141.36% | -515.08% | 4993.94% | 4045.68% | - | Upgrade
|
| Depreciation & Amortization | 0.11 | 0.07 | 0.07 | 0.02 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | Upgrade
|
| EBIT | -7.63 | -10.17 | -12.62 | -14.44 | -12.63 | -5.41 | -4.08 | 8.22 | 6.54 | 6.99 | Upgrade
|
| EBIT Margin | -1027.46% | -1255.93% | -1478.90% | -1892.92% | -621.31% | -141.73% | -517.49% | 4983.03% | 4035.80% | - | Upgrade
|
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).